Fenofibrate Nanocrystallized
Brand name: Fenofibrate
Rank #396 of 500 drugs by total cost
$23.2M
Total Cost
602,181
Total Claims
$23.2M
Total Cost
23,488
Prescribers
$38
Cost per Claim
50,688
Beneficiaries
1,284,738
30-Day Fills
$987
Avg Cost/Provider
26
Avg Claims/Provider
About Fenofibrate Nanocrystallized
Fenofibrate Nanocrystallized (sold as Fenofibrate) was prescribed 602,181 times by 23,488 Medicare Part D providers in 2023, costing the program $23.2M. At $38 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 393 | Lactulose (Lactulose) | $23.6M | 538,677 |
| 394 | Siponimod (Mayzent) | $23.5M | 2,195 |
| 395 | Droxidopa (Droxidopa) | $23.4M | 9,058 |
| 396 | Fenofibrate Nanocrystallized (Fenofibrate) | $23.2M | 602,181 |
| 397 | Ravulizumab-Cwvz (Ultomiris) | $23.1M | 428 |
| 398 | Roflumilast (Roflumilast) | $22.8M | 97,022 |
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology